Literature DB >> 19879789

Relationship between uric acid and hepatic steatosis among Koreans.

K Lee1.   

Abstract

AIM: The relationship between high uric-acid levels and hepatic steatosis, according to body mass index (BMI) categories, and their coexistence with the metabolic syndrome (MetS) were examined in the present study.
METHODS: The study involved a cross-sectional sample of 13,621 Koreans (7221 men and 6400 women) who visited a health checkup centre between 2005 and 2006. Hepatic steatosis was diagnosed using ultrasonography. Hyperuricaemia was defined as >7mg/dL for men and >6mg/dL for women. The MetS was defined as the presence of three or more MetS components-obesity (BMI >or=25.0kg/m(2)), high blood pressure, elevated levels of triglycerides and glucose, and low levels of high-density lipoprotein (HDL)-cholesterol.
RESULTS: In total, 26.2% were diagnosed with hepatic steatosis, of whom 11.9% were non-obese (BMI <25kg/m(2)) and 52.5% were obese. Hyperuricaemia was associated with hepatic steatosis in non-obese (adjusted odds ratio [AOR] of 1.4 in men and 2.2 in women) as well as in obese individuals (AOR of 1.8 in men and 2.3 in women) after adjusting for age, other MetS components and liver function tests. The AOR (95% CI) for hepatic steatosis in obese individuals with hyperuricaemia compared with non-obese individuals with normal uric-acid levels was 7.7 (6.4-9.3) in men and 12.4 (7.8-19.5) in women. The adjusted age and liver-function test ORs (95% CI) for hepatic steatosis in those with hyperuricaemia and no MetS compared with those who had normal uric acid levels and no MetS were 2.0 (1.7-2.4) in men and 3.2 (2.1-4.9) in women. The ORs (95% CI) in those with hyperuricaemia and the MetS increased to 6.9 (5.5-8.8) and 15.2 (8.4-27.4) in men and women, respectively.
CONCLUSION: Hyperuricaemia is independently associated with hepatic steatosis regardless of BMI category or the presence of the MetS in Korean adults. Further research into the causal relationship is needed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19879789     DOI: 10.1016/j.diabet.2009.04.011

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  18 in total

Review 1.  Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations.

Authors:  Robert J Wong; Aijaz Ahmed
Journal:  World J Hepatol       Date:  2014-05-27

2.  Relation of uric acid to serum levels of high-sensitivity C-reactive protein, triglycerides, and high-density lipoprotein cholesterol and to hepatic steatosis.

Authors:  Tanya Keenan; Michael J Blaha; Khurram Nasir; Michael G Silverman; Rajesh Tota-Maharaj; Jose A M Carvalho; Raquel D Conceição; Roger S Blumenthal; Raul D Santos
Journal:  Am J Cardiol       Date:  2012-09-10       Impact factor: 2.778

3.  Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific.

Authors:  Roslyn Vongsuvanh; David van der Poorten; Jacob George
Journal:  Hepatol Int       Date:  2013-07-31       Impact factor: 6.047

4.  Sodium butyrate recovers high-fat diet-fed female Wistar rats from glucose dysmetabolism and uric acid-associated cardiac tissue damage.

Authors:  Caroline Badejogbin; Damilare E Areola; Kehinde S Olaniyi; Oluwaseun A Adeyanju; Isaac O Adeosun
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-06-29       Impact factor: 3.000

5.  Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver.

Authors:  Miguel A Lanaspa; Laura G Sanchez-Lozada; Yea-Jin Choi; Christina Cicerchi; Mehmet Kanbay; Carlos A Roncal-Jimenez; Takuji Ishimoto; Nanxing Li; George Marek; Murat Duranay; George Schreiner; Bernardo Rodriguez-Iturbe; Takahiko Nakagawa; Duk-Hee Kang; Yuri Y Sautin; Richard J Johnson
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

Review 6.  NAFLD in Asia--as common and important as in the West.

Authors:  Geoffrey C Farrell; Vincent Wai-Sun Wong; Shiv Chitturi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-05       Impact factor: 46.802

Review 7.  Fructose and cardiometabolic disorders: the controversy will, and must, continue.

Authors:  Nicolas Wiernsperger; Alain Geloen; Jean-Robert Rapin
Journal:  Clinics (Sao Paulo)       Date:  2010-07       Impact factor: 2.365

8.  Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway.

Authors:  In-Jin Cho; Da-Hee Oh; Jin Yoo; You-Cheol Hwang; Kyu Jeung Ahn; Ho-Yeon Chung; Soung Won Jeong; Ju-Young Moon; Sang-Ho Lee; Sung-Jig Lim; In-Kyung Jeong
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

Review 9.  Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology.

Authors:  Richard J Johnson; Peter Stenvinkel; Sandra L Martin; Alkesh Jani; Laura Gabriela Sánchez-Lozada; James O Hill; Miguel A Lanaspa
Journal:  Obesity (Silver Spring)       Date:  2013-04       Impact factor: 5.002

10.  Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver.

Authors:  Miguel A Lanaspa; Laura G Sanchez-Lozada; Christina Cicerchi; Nanxing Li; Carlos A Roncal-Jimenez; Takuji Ishimoto; Myphuong Le; Gabriela E Garcia; Jeffrey B Thomas; Christopher J Rivard; Ana Andres-Hernando; Brandi Hunter; George Schreiner; Bernardo Rodriguez-Iturbe; Yuri Y Sautin; Richard J Johnson
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.